Cover ImageSALE
市場調查報告書

關節內粘稠補充療法的全球市場:2016年∼2020年

Global Viscosupplementation Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 397926
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
關節內粘稠補充療法的全球市場:2016年∼2020年 Global Viscosupplementation Market 2016-2020
出版日期: 2016年11月11日 內容資訊: 英文 80 Pages
簡介

全球關節內粘稠補充療法市場預測在2016年∼2020年間,將以年複合成長率 (CAGR) 6.23%的速度成長。

本報告提供全球關節內粘稠補充療法市場相關調查分析,提供您市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 調查範圍

  • 市場概要
  • 供應商分析
  • 主要供應商產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 主要市場亮點

第5章 關節內粘稠補充療法的全球市場:形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 關節內粘稠補充療法的全球市場:各產品

  • 市場概要
  • 單劑量
  • 3次給藥
  • 5次給藥

第7章 關節內粘稠補充療法的全球市場:各地區

  • 市場概要
  • 南北美洲
  • 歐洲·中東·非洲
  • 亞太地區

第8章 關節內粘稠補充療法的全球市場:推動因素

第9章 推動因素的影響

第10章 關節內粘稠補充療法的全球市場:課題

第11章 推動因素與課題的影響

第12章 關節內粘稠補充療法的全球市場:趨勢

第13章 業者情勢

  • 競爭模式
  • 市場供應商排行榜分析

第14章 主要供應商分析

  • 地區性佔有率:主要供應商分析
  • Sanofi
  • Anika Therapeutics
  • 生化學工業
  • Fidia Farmaceutici
  • Ferring Pharmaceuticals
  • 其他卓越供應商

第15章 附錄

第16章 關於Technavio

目錄
Product Code: IRTNTR10769

About Viscosupplementation

Viscosupplementation is a minimally invasive treatment for knee osteoarthritis. It involves the injection of hyaluronic acid into a knee joint to assist the viscous properties of synovial fluid. The procedure increases the joint's functioning and reduces pain. Intra-articular viscosupplementation with hyaluronic acid is gaining acceptance as it is a non-invasive procedure compared to knee replacement. It is categorized into three product segments -- single-injection cycle, three-injection cycle, and five-injection cycle.

Technavio's analysts forecast the global Viscosupplementation market to grow at a CAGR of 6.23% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global Viscosupplementation market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products in different regions.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Viscosupplementation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Sanofi
  • Anika Therapeutics
  • Seikagaku
  • Fidia Farmaceutici
  • Ferring Pharmaceuticals

Other Prominent Vendors

  • Allergan
  • Contipro Biotech
  • DePuy Synthes
  • F. Hoffmann-La Roche
  • Galderma
  • HTL Biotechnology
  • Hyaltech
  • Expanscience Laboratoires
  • Lifecore Biomedical
  • Lipo Chemicals
  • Merz Aesthetics
  • Mylan
  • Nordic Drugs
  • Shandong Freda Biochem
  • Shanghai Jingfeng Pharmaceutical
  • Smith & Nephew
  • TEIJIN PHARMA
  • TRB Chemedica International

Market driver

  • Fast-growing geriatric population
  • For a full, detailed list, view our report

Market challenge

  • Threat from substitutes
  • For a full, detailed list, view our report

Market trend

  • Increasing patient preference for single-injection cycle
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Vendor analysis
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by products

  • Market overview
  • Single-injection cycle market
  • Three-injection cycle market
  • Five-injection cycle market

PART 07: Geographical segmentation

  • Market overview
  • Viscosupplementation market in Americas
  • Viscosupplementation market in EMEA
  • Viscosupplementation market in APAC

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

  • Competitive scenario
  • Market vendor ranking analysis 2015

PART 14: Key vendor analysis

  • Geographic presence: Key vendor analysis
  • Sanofi
  • Anika Therapeutics
  • Seikagaku
  • Fidia Farmaceutici
  • Ferring Pharmaceuticals
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Key countries
  • Exhibit 02: Global viscosupplementation market segmentation: Overview
  • Exhibit 03: Product offerings
  • Exhibit 04: Snapshot: Global viscosupplementation market
  • Exhibit 05: Global viscosupplementation market: Key impacting factors
  • Exhibit 06: Growth perspective in developed and emerging markets
  • Exhibit 07: Global viscosupplementation market 2015-2020 ($ billions)
  • Exhibit 08: Impact of various factors on global viscosupplementation market
  • Exhibit 09: Five forces analysis
  • Exhibit 10: Global viscosupplementation market by product type 2015 and 2020
  • Exhibit 11: Global viscosupplementation market segmentation by product type 2015-2020 (% share)
  • Exhibit 12: Impact of product segments in global viscosupplementation market
  • Exhibit 13: Global single-injection cycle market 2015-2020 ($ billions)
  • Exhibit 14: Global three-injection cycle market 2015-2020 ($ billions)
  • Exhibit 15: Global five-injection cycle market 2015-2020
  • Exhibit 16: Global viscosupplementation market by five-injection cycle procedure 2015-2020 ($ billions)
  • Exhibit 17: Global viscosupplementation market by geography 2015 and 2020 (% share)
  • Exhibit 18: Global viscosupplementation market by geography 2015-2020 (% share)
  • Exhibit 19: Snapshot: Global viscosupplementation market by geography
  • Exhibit 20: Viscosupplementation market in Americas 2015-2020 ($ billions)
  • Exhibit 21: Viscosupplementation market in EMEA ($ billions)
  • Exhibit 22: Viscosupplementation market in APAC ($ billions)
  • Exhibit 23: Impact of drivers
  • Exhibit 24: Impact of drivers and challenges
  • Exhibit 25: Strategic success factor of companies
  • Exhibit 26: Competitive parameters in global viscosupplementation market
  • Exhibit 27: Global viscosupplementation market vendor analysis 2015
  • Exhibit 28: Regional analysis of key vendors
  • Exhibit 29: Sanofi profile
  • Exhibit 30: Sanofi strength analysis
  • Exhibit 31: Sanofi growth strategy matrix
  • Exhibit 32: Sanofi: Opportunity assessment
  • Exhibit 33: Anika Therapeutics profile
  • Exhibit 34: Anika Therapeutics strength analysis
  • Exhibit 35: Anika Therapeutics growth strategy matrix
  • Exhibit 36: Anika Therapeutics: Opportunity assessment
  • Exhibit 37: Seikagaku profile
  • Exhibit 38: Seikagaku strength analysis
  • Exhibit 39: Seikagaku growth strategy matrix
  • Exhibit 40: Seikagaku: Opportunity assessment
  • Exhibit 41: Fidia Farmaceutici profile
  • Exhibit 42: Fidia Farmaceutici strength analysis
  • Exhibit 43: Fidia Farmaceutici growth strategy matrix
  • Exhibit 44: Fidia Farmaceutici: Opportunity assessment
  • Exhibit 45: Ferring Pharmaceuticals profile
  • Exhibit 46: Ferring Pharmaceuticals strength analysis
  • Exhibit 47: Ferring Pharmaceuticals growth strategy matrix
  • Exhibit 48: Ferring Pharmaceuticals: Opportunity assessment
Back to Top